Dr. Kloiber’s research focuses on improving treatment of depression and anxiety disorders by individualizing therapy through biomarker research and investigating novel approaches. By combining various strategies (genomics, neuroendocrinology, metabolomics and psychophysiology), Dr. Kloiber aims to detect individual biological signatures for prediction of treatment response, prevention of adverse events and biological subclassification of depression and anxiety disorders. He is particularly interested in biological mechanisms underlying the intersection of mood and anxiety disorders, metabolism and metabolic disorders. His scientific and clinical work is directed towards improvement of therapy for treatment-resistant depression and anxiety disorders through implementation and evaluation of evidence-based treatment algorithms and the clinical investigation of novel treatment strategies.
Dr. Stefan Kloiber
Brain and Therapeutics
T: (416) 535-8501 32503
Centre for Addiction & Mental Health
100 Stokes St
Toronto, ON, M6J 1H4
Dr. Stefan Kloiber is a Psychiatrist and Clinician Scientist in the Mood and Anxiety Division at the Centre for Addiction and Mental Health (CAMH).